Overview

Targeted Busulfan, Fludarabine Conditioning Regimen for Hematopoietic Stem Cell Transplantation in GRD

Status:
Recruiting
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
To evaluate the outcome of hematopoietic stem cell transplantation using targeted busulfan, fludarabine conditioning regimen in genetic rare disease
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Seoul National University Hospital
Treatments:
Busulfan
Fludarabine
Fludarabine phosphate